RIVM_Logo_Engels

Reduction of therapeutic efficacy by a second cycle of PEG-IL-2.

 

Home / Documents and publications / Reduction of therapeutic efficacy by a second cycle of PEG-IL-2.

RIVM Committed to health and sustainability
Menu